ARCHIVES

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Armitage Appointed to NCAB; UT Board Approves New Clinical Building for MDACC

May 19, 2000

Garfinkel to Retire From ACS; Health to Succeed Him

July 20, 1990

Obama Signs Bill Giving FDA Authority Over Tobacco Products

June 26, 2009

$1 Million Gift to Duke Funds Urologic Research Center.

November 24, 2000

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007